Skip to main content

Table 9 Perioperative and long-term outcome after pancreatic resection for intraductal papillary mucinous neoplasm (IPMN)

From: Pancreatic resection for intraductal papillary mucinous neoplasm– a thirteen-year single center experience

Series number of patients non-invasive IPMNa (n/%) Invasive IPMNa (n/%) Perioperative mortality (n/%) Perioperative morbidity (Clavien Dindo/others; n(%)) Survival Recurrence rate Comment
Salvia et al. [44] n = 140 47 (34 %) 83 (66 %) 0 33 (24 %)(major complication) 10-year overall survival non-invasive IPMNa 100 %; invasive IPMNa: 50 %. n.s.b  
Sohn et al. [14] n = 136 84 (62 %) 52 (38 %) 5 (3.7 %) 47 (35 %) 5-year overall survival non-invasive IPMNa :77 %; invasive. IPMNa: 43 %. n.s.b  
D'Angelica et al. [15] n = 62 a 33a (52 %) 30 (48 %) 4 (6 %) 31 (50 %) 5-year-overall survival:75 %/10 year-overall survival:60 % 23 % a 1 patient Unresectable
Rodriguez et al. [39] n = 145 113 (78 %) 32 (22 %) 0 86 (59 %) 10-year-overall survival: 70 %, invasive Carcinoma : 10-year-overall survival: 63 % 6.9 % only branch duct-IPMNa
Niedergethmann [20] n = 97 29 (30 %) 68 (70 %) 1 (1 %) 55 (56.7 %) median overall survival: 36 months n.s.b  
Sahora et al. [35] n = 226 174 (77 %) 52 (23 %) 1.3 % 34 % n.s. 8.5 % only branch-duct-IPMNa
Marchegiani et al. [21] n = 173 48 (28 %) 125 (72 %) 0 15.6 % ("major surgical complications") 10 year-overall survival: 69 % 25 % only main-duct-IPMNa
present series n = 54 24 (44 %) 30 (56 %) 2 (3.7 %) 20 (37 %) 5-year-overall survival non-invasive IPMNa: 100 %, invasive IPMNa 69 % 6 (12 %)  
  1. aIPMN intraductal papillary mucinous neoplasm
  2. bn.s. not specified